124 related articles for article (PubMed ID: 8234171)
1. Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature.
Monteiro-Riviere NA; Inman AO; Riviere JE; McNeill SC; Francoeur ML
Pharm Res; 1993 Sep; 10(9):1326-31. PubMed ID: 8234171
[TBL] [Abstract][Full Text] [Related]
2. Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application.
Dancik Y; Anissimov YG; Jepps OG; Roberts MS
Br J Clin Pharmacol; 2012 Apr; 73(4):564-78. PubMed ID: 21999217
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin.
Higaki K; Nakayama K; Suyama T; Amnuaikit C; Ogawara K; Kimura T
Int J Pharm; 2005 Jan; 288(2):227-33. PubMed ID: 15620862
[TBL] [Abstract][Full Text] [Related]
4. In vitro percutaneous absorption of piroxicam through synthetic membranes and abdominal rat skin.
Santoyo S; Arellano A; Ygartua P; Martín C
Pharm Acta Helv; 1996 Jul; 71(2):141-6. PubMed ID: 8810580
[TBL] [Abstract][Full Text] [Related]
5. Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation.
Murthy SN; Zhao YL; Sen A; Hui SW
J Control Release; 2004 Oct; 99(3):393-402. PubMed ID: 15451597
[TBL] [Abstract][Full Text] [Related]
6. Enhanced percutaneous absoption of piroxicam via salt formation with ethanolamines.
Cheong HA; Choi HK
Pharm Res; 2002 Sep; 19(9):1375-80. PubMed ID: 12403076
[TBL] [Abstract][Full Text] [Related]
7. Topical Nonsteroidal Anti-Inflammatory Drugs: The Importance of Drug, Delivery, and Therapeutic Outcome.
Barkin RL
Am J Ther; 2015; 22(5):388-407. PubMed ID: 22367354
[TBL] [Abstract][Full Text] [Related]
8. Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application.
Santoyo S; Ygartua P
Eur J Pharm Biopharm; 2000 Sep; 50(2):245-50. PubMed ID: 10962234
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo Skin Permeation Evaluation of An Innovative Transdermal Vehicle Using Nimesulide and Piroxicam as Model Drugs.
Pereira RO; Pelisson E Silva TCC; de Oliveira Ferreira A; Brandao MAF; Raposo NRB; Polonini HC
Curr Drug Deliv; 2017; 14(4):516-520. PubMed ID: 27557671
[TBL] [Abstract][Full Text] [Related]
10. Effect of ethanolamine salts and enhancers on the percutaneous absorption of piroxicam from a pressure sensitive adhesive matrix.
Cheong HA; Choi HK
Eur J Pharm Sci; 2003 Feb; 18(2):149-53. PubMed ID: 12594008
[TBL] [Abstract][Full Text] [Related]
11. Topical absorption of piroxicam from organogels--in vitro and in vivo correlations.
Pénzes T; Blazsó G; Aigner Z; Falkay G; Eros I
Int J Pharm; 2005 Jul; 298(1):47-54. PubMed ID: 15893893
[TBL] [Abstract][Full Text] [Related]
12. Local enhanced topical delivery (LETD) of drugs: does it truly exist?
McNeill SC; Potts RO; Francoeur ML
Pharm Res; 1992 Nov; 9(11):1422-7. PubMed ID: 1475228
[TBL] [Abstract][Full Text] [Related]
13. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
14. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
[TBL] [Abstract][Full Text] [Related]
15. Skin disposition of drugs after topical application in hairless rats.
Yanagimoto G; Hayashi T; Hasegawa T; Seki T; Juni K; Sugibayashi K; Morimoto Y
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):749-54. PubMed ID: 10399833
[TBL] [Abstract][Full Text] [Related]
16. Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application.
Cross SE; Megwa SA; Benson HA; Roberts MS
Pharm Res; 1999 Mar; 16(3):427-33. PubMed ID: 10213375
[TBL] [Abstract][Full Text] [Related]
17. Plasma and cutaneous drug levels after topical application of piroxicam gel: a study in healthy volunteers.
Marks R; Dykes P
Skin Pharmacol; 1994; 7(6):340-4. PubMed ID: 7946377
[TBL] [Abstract][Full Text] [Related]
18. [Effect of enhancers on cutaneous permeation of piroxicam in vitro].
Xu GQ; Xi NZ; Chen GS; Jiang XG; Xu HN
Zhongguo Yao Li Xue Bao; 1991 May; 12(3):235-8. PubMed ID: 1781286
[TBL] [Abstract][Full Text] [Related]
19. Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs.
Djordjevic J; Michniak B; Uhrich KE
AAPS PharmSci; 2003 Oct; 5(4):E26. PubMed ID: 15198514
[TBL] [Abstract][Full Text] [Related]
20. In vitro topical delivery of non-steroidal anti-inflammatory drugs through human skin.
Vincent CM; Laugel C; Marty JP
Arzneimittelforschung; 1999 Jun; 49(6):509-13. PubMed ID: 10417867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
